Cardiol Therapeutics Inc.

Informe acción TSX:CRDL

Capitalización de mercado: CA$183.0m

Salud financiera de hoja de balance de Cardiol Therapeutics

Salud financiera controles de criterios 6/6

Cardiol Therapeutics tiene un patrimonio de los accionistas total de CA$10.4M y una deuda total de CA$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son CA$17.5M y CA$7.1M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

CA$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoCA$15.89m
PatrimonioCA$10.43m
Total pasivoCA$7.09m
Activos totalesCA$17.52m

Actualizaciones recientes sobre salud financiera

Recent updates

We're Not Very Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Sep 12
We're Not Very Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?

May 01
Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?

Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely?

Jan 06
Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely?

Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?

Sep 13
Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?

We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully

May 24
We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully

We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth

Jan 20
We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth

We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth

Aug 10
We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth

We're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn

Apr 17
We're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn

Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation

Dec 09
Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation

We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully

Aug 19
We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation

Apr 18
Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation

Companies Like Cardiol Therapeutics (TSE:CRDL) Are In A Position To Invest In Growth

Jan 03
Companies Like Cardiol Therapeutics (TSE:CRDL) Are In A Position To Invest In Growth

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CA$17.3M) de CRDL superan a sus pasivos a corto plazo (CA$7.0M).

Pasivo a largo plazo: Los activos a corto plazo de CRDL (CA$17.3M) superan a sus pasivos a largo plazo (CA$134.2K).


Historial y análisis de deuda-patrimonio

Nivel de deuda: CRDL está libre de deudas.

Reducción de la deuda: CRDL no tenía deudas hace 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: CRDL tiene suficiente cash runway para 7 meses según el flujo de caja libre último declarado, pero desde entonces ha obtenido capital adicional.

Pronóstico de cash runway: Se prevé que CRDL disponga de suficiente cash runway para 6 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.


Descubre empresas con salud financiera